|
|
|
| Distribution and drug resistance of pathogenic bacteria isolated from blood culture in outpatients |
| WU Qing, CHEN Lijiang, XU Chunquan, ZHOU Cui, ZHANG Xueqing, YU Fangyou, ZHOU Tieli. |
Center for Clinical Laboratory, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015
|
|
| Cite this article: |
|
WU Qing,CHEN Lijiang,XU Chunquan, et al. Distribution and drug resistance of pathogenic bacteria isolated from blood culture in outpatients[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2016, 46(3): 211-214.
|
|
|
Abstract Objective: To investigate distribution and drug resistance of pathogenic bacteria isolated from blood culture in outpatients, to provide reference for the clinical rational use of antibiotics. Methods: Blood samples were cultured by BacT/Alert 3D automated system, the identification of strains and the drug susceptibility testing were performed by VITEK 2 COMPACT system, the data were analyzed with Whonet 5.6 software. Results: Totally 1 221 strains were isolated from 7 774 blood culture specimens in outpatients, with the positive rate of 15.7%, there were 569 positive cultures after the repeated strains were get rid of. Among the bacterial strains ,the percentages of the gram-negative bacteria, gram-positive bacteria and fungi were 57.1% (325 strains), 41.7% (237 strains) and 1.2% (7 strains), respectively. Pathogenic bacteria resistance rate was relatively low, the positive rate of ESBLs in Klebsiella pneumoniae was 11.1%, resistance of methicillin-resistant Staphylococcus aureus isolation rate was 28.6%; separation of Enterobacteriaceae to carbapenem antibacterial drug resistance<1.0%, vancomycin resistant Staphylococcus aureus did not be found. Conclusion: The main pathogens of outpatient blood culture are Staphylococcus aureus, Escherichia coli and Klebsiella pneumoniae, and these bacteria are better sensitivity to commonly used antibiotics in clinical practice.
|
|
Received: 19 May 2015
|
| |
|
|
|
[1] RIEDEL S, CARROLL K C. Blood cultures: key elements for best practices and future directions[J]. J Infect Chemother, 2010, 16(5): 301-316.
[2] Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing[S]. CLSI, 2011.
[3] 郑卫东, 袁仕伟, 李莲. 1368例血培养标本病原菌种类及耐药性分析[J]. 国际检验医学杂志, 2011, 32(18): 2099-2101．
[4] 李学文, 孙伏喜, 赵水娣, 等. 2008-2011年495份血培养 标本病原菌分布及其耐药性[J]. 中华医院感染学杂志, 2012, 22(23): 5396-5398.
[5] 夏涵, 刘智勇, 任章银, 等. 24141份血培养病原菌的分布及耐药性分析[J]. 中华医院感染学杂志, 2012, 22(20): 4607-4610.
[6] 强雪芹, 张爽, 辛力华, 等. 2011-2012年血培养病原菌分布及耐药性变迁[J]. 中华医院感染学杂志, 2014, 24(1):36-38.
[7] 姚丹, 余方友, 黄晓颖, 等. 引起血流感染的大肠埃希菌的 耐药谱分析[J]. 温州医科大学学报, 2014, 44(12): 917-919.
[8] 吕媛, 李耘, 薛峰, 等. 卫生部全国细菌耐药监测网(Mohnarin)2011-2012年度血流感染细菌耐药监测报告[J]. 中国临床药理学杂志, 2014, 30(3): 278-288. |
|
|
|
